HomeAI · summaries
Storia in 2 fonti
Novo Nordisk hits out at rival Hims & Hers over cheaper weight-loss pill
US telehealth group will sell product for $49 a month, a third that of its Danish competitor
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
cnbc.com
Novo Nordisk and Eli Lilly fall after Hims & Hers announce $49 copy of Wegovy pill
Novo Nordisk and Eli Lilly fell after Hims & Hers said it will offer a copy of the Wegovy pill for $49, far less than the $149 Novo sells the branded pill for.
- ·
ft.com
Novo Nordisk hits out at rival Hims & Hers over cheaper weight-loss pill
US telehealth group will sell product for $49 a month, a third that of its Danish competitor
- ·
White House launches TrumpRx as drug companies warn of sales hit
Platform offers discounts for weight-loss and fertility medicines sold by Novo Nordisk, Eli Lilly and others
- ·
Hims & Hers abandons copycat weight-loss drug in face of FDA probe
Novo Nordisk had accused the telehealth company of breaching its patent on Wegovy